Prevalence and severity of cognitive impairment with and without dementia in an elderly population

Lancet

Volumn 349, Issue 9068, 1997, Pages 1793-1796

  Graham, Janice E ^a   Rockwood, Kenneth ^a   Beattie, B Lynn ^b   Eastwood, Robin ^c   Gauthier, Serge ^d   Tuokko, Holly ^e   McDowell, Ian ^e  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMNESIA; ARTICLE; CANADA; COGNITIVE DEFECT; COMPREHENSION; DEMENTIA; HUMAN; PRIORITY JOURNAL; SCREENING;

EID: 0030909279     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)01007-6     Document Type: Article

References (27)

1. Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994; 44: 227-32.
2. Rich JB, Rasmusson DX, Folstein MF, Carson KA, Kawas C, Brandt J. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995; 45: 51-55.
3. Anderson K, Launer LJ, Ott A, Hoes AW, Breteler MMB, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology 1995; 45: 1441-45.
4. Skoog I, Levnfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-45.
5. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429-32.
6. Birge SJ. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 1996; 44: 865-70.
7. Rozzini R, Ferrucci L, Losonczy K, Havlik RJ, Guralnik JM. Protective effect of chronic NSAID use on cognitive decline in older persons. J Am Geriatr Soc 1996; 44: 1025-29.
8. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet 1997; 349: 763-65.
9. Writing Committee, Lancet Conference 1996. The challenge of the dementias. Lancet 1996; 347: 1303-07.
10. Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging: study methods and prevalence of dementia. Can Med Assoc J 1994; 150: 899-913.
11. Graham JE, Rockwood K, Beattie BL, McDowell I, Eastwood R, Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology 1996; 15: 246-56.
12. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment of the nondemented elderly. Arch Neurol 1995; 52: 612-19.
13. Teng EL, Chui HC. The modified mini-mental state (3MS) examination. J Clin Psychiatry 1987; 48: 314-18.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn. Washington, DC: American Psychiatric Association, 1987.
15. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon SG. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change - report of a National Institutes of Health Working Group. Dev Neuropsychol 1986; 2: 261-76.
16. Blackford RC, LaRue A. Criteria for diagnosing age-associated memory impairment: proposed revisions from the field. Dev Neuropsychol 1989; 5: 295-306.
17. Zaudig M. A new systematic method of measurement and diagnosis of "mild cognitive impairment" and dementia according to ICD-10 and DSM-II-R criteria. Int Psychogeriatr 1992; 4 (suppl 2): 203-19.
18. Cochran WG. Sampling techniques, 3rd edn. New York: John Wiley, 1977.
19. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of dementia. Br J Psychiatry 1986; 149: 698-709.
20. Ostbye T, Crosse E. Net economic costs of dementia in Canada. Can Med Assoc J 1994; 151: 1457-64.
21. Pfeffer RI, Afifi AA, Chance JM. Prevalence of Alzheimer's disease in a retirement community. Am J Epidemiol 1987; 125: 420-35.
22. Evans DA, Funkelsteim H, Albert MS, et al. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989; 269: 2551-56.
23. Morris JC, Storandt M, McKeel DW, et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996; 46: 707-19.
24. Reiman EM, Casdelli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the E4 allele for apoliporotein E. N Engl J Med 1996; 334: 752-58.
25. Persson G, Skoog I. Subclinical dementia: relevance of cognitive symptoms and signs. J Geriatr Psychiatry Neurol 1992; 5: 172-78.
26. Flicker C, Ferris SH, Reisberg B. A two-year longitudinal study of cognitive function in normal aging and Alzheimer's disease. J Geriatr Psychiatry Neurol 1993; 6: 84-96.
27. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996; 46: 661-65.